WuXi Biologics - Net Income From Continuing Operations

WuXi Biologics's Fiscal Year is From January To December - All Figures are in CNY, Millions.

The item "Net-Income-From-Continuing-Operations" stands at 280.43 Million Chinese Yuans for the trailing twelve months (TTM) period ending 09/30/2020, the lowest value since 12/31/2018.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -32.46 percent compared to the value the year prior.
The 1 year change in percent is -32.46.
The 3 year change in percent is 508.32.

The Serie's long term average value is 270.49 Million Chinese Yuans. It's latest available value, on 09/30/2020, is 3.67 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2017, to it's latest available value, on 09/30/2020, is +508.32%.
The Serie's change in percent from it's maximum value, on 12/31/2019, to it's latest available value, on 09/30/2020, is -44.49%.